Radiko Holdings Corp. Share Price Canadian Securities Exchange
Equities
JUJU
CA75034R1029
Pharmaceuticals
Sales 2018 | 107K 145K 8.89M | Sales 2019 | 5.18M 7.05M 432M | Capitalization | 6.17M 8.39M 514M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.44M -334M | Net income 2019 | -10M -13.6M -834M | EV / Sales 2018 | 101 x |
Net Debt 2018 | 259K 352K 21.57M | Net Debt 2019 | 1.98M 2.7M 165M | EV / Sales 2019 | 1.57 x |
P/E ratio 2018 |
-1.5
x | P/E ratio 2019 |
-0.53
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 96.73% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16/18/16 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 10/19/10 |
Scott Reeves
BRD | Director/Board Member | 55 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16/18/16 |
Scott Reeves
BRD | Director/Board Member | 55 | 01/17/01 |
Robert Yosaitis
BRD | Director/Board Member | - | 12/19/12 |
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |